Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update investigating intensive therapy with continuous subcutaneous insulin infusion on beta-cell function in newly d…
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control [Phase 3]
Phase 3 trial evaluating saxagliptin added to insulin therapy in Chinese patients with Type 2 Diabetes inadequately controlled on insulin al…
-
CLINICAL_TRIALS withdrawal · 2017-10-02Clinical Trial Update: Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics [Phase 4]
A Phase 4 trial evaluating aliskiren versus hydrochlorothiazide in hypertensive patients with type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: The Effects of Barberry Juice Consumption in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial examining the effects of barberry juice consumption in patients with type 2 diabetes has been completed.
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes [Phase 4]
A Phase 4 trial comparing exenatide vs metformin monotherapy in overweight/obese patients with newly diagnosed type 2 diabetes has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-09-29FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for AFREZZA (insulin human) from Mannkind Corporation.
-
FDA approval · 2017-09-29FDA Approved: FIASP — Original Application (Novo Nordisk)
FDA approves the original application for FIASP (insulin aspart injection) by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO) [Phase 3]
Phase 3 trial update for ertugliflozin monotherapy in type 2 diabetes patients not adequately controlled with diet and exercise; study compl…
-
FDA approval · 2017-09-28FDA Approved: SOLIQUA 100/33 — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Soliqua 100/33, the fixed-ratio combination of insulin glargine and lixisenatide, submitted …
-
EMA approval · 2017-09-28EMA Authorised: NovoNorm (repaglinide) — Novo Nordisk A/S
The EMA authorised NovoNorm (repaglinide) for type 2 diabetes, marking its approval in the European Union.
-
CLINICAL_TRIALS trial_result · 2017-09-28Clinical Trial Update: Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting [Phase 4]
Phase 4 trial comparing NPH and Lantus-based insulin regimens for hypoglycemia management in hospitalized noncritical patients with type 2 d…
-
CLINICAL_TRIALS trial_result · 2017-09-21Clinical Trial Update: Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes Mellitus [Phase 1, Phase 2]
Phase 1/2 trial investigating bone marrow mononuclear cells with hyperbaric oxygen therapy for Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-21Clinical Trial Update: Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure [Phase 4]
Phase 4 trial evaluating exenatide in people with type 2 diabetes and diastolic heart failure was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-19Clinical Trial Update: Effect of Folic Acid and Vitamin B12 Supplementation in Subjects With Type 2 Diabetes [Phase 2, Phase 3]
Phase 2/3 trial investigating folic acid and vitamin B12 supplementation in adults with type 2 diabetes completed.
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus [Phase 3]
Phase III study evaluating added exenatide versus placebo to titrated basal insulin glargine in inadequately controlled type 2 diabetes pati…
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration [NA]
A completed clinical trial evaluating a prototype diabetes management system for insulin initiation and titration.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone [Phase 3]
Phase III study evaluating dapagliflozin (BMS-512148) in Asian patients with Type 2 diabetes inadequately controlled on metformin; trial com…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Safety and Efficiency of Linagliptin (Trajenta) in the Setting of Internal Medicine Department [Phase 3]
Phase 3 trial update evaluating safety and efficacy of linagliptin (Trajenta) in type 2 diabetes patients, with unknown overall status.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Correlation Between Plasma- and Endothelial DPP-4 Activity [Phase 4]
Phase 4 trial update investigating correlation between plasma- and endothelial DPP-4 activity in people with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2017-09-01Clinical Trial Update: Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients [Phase 4]
Phase 4 trial comparing ticagrelor and clopidogrel in patients with type 2 diabetes and coronary artery disease has completed with results p…
-
CLINICAL_TRIALS trial_result · 2017-09-01Clinical Trial Update: Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)
A completed post-marketing surveillance trial evaluating the safety of using liraglutide (Victoza) in patients with Type 2 diabetes mellitus…
-
CLINICAL_TRIALS research · 2017-09-01Clinical Trial Update: Vitamin C as an Adjunct in Periodontal Treatment in Type 2 Diabetes Mellitus Patients [Phase 2]
A Phase 2 clinical trial evaluating Vitamin C as an adjunct to periodontal treatment in patients with type 2 diabetes mellitus and periodont…
-
CLINICAL_TRIALS safety_alert · 2017-08-30Clinical Trial Update: Sodium-glucose Co-transporter 2 (SGLT2) Inhibitor Risk of Below-Knee Lower Extremity Amputation: A Retrospective Cohort Study Using a Large Claims Database in the United States
A retrospective cohort study using a large US claims database examines the risk of below-knee lower extremity amputation associated with SGL…
-
FDA approval · 2017-08-29FDA Approved: SOLIQUA 100/33 — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Soliqua 100/33, the fixed-ratio combination of insulin glargine and lixisenatide, submitted by S…
-
FDA approval · 2017-08-25FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for liraglutide submitted by Teva Pharmaceuticals USA, Inc.